US Bancorp’s Rocket Pharmaceuticals RCKT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $6.53K | Sell |
1,824
-1,163
| -39% | -$4.62K | ﹤0.01% | 3494 |
|
|
2025
Q4 | $10.5K | Buy |
2,987
+2,040
| +215% | +$6.99K | ﹤0.01% | 3319 |
|
|
2025
Q3 | $3.09K | Sell |
947
-649
| -41% | -$2.04K | ﹤0.01% | 3676 |
|
|
2025
Q2 | $3.91K | Buy |
1,596
+182
| +13% | +$922 | ﹤0.01% | 3711 |
|
|
2025
Q1 | $9.43K | Sell |
1,414
-58
| -4% | -$573 | ﹤0.01% | 3455 |
|
|
2024
Q4 | $18.5K | Buy |
1,472
+620
| +73% | +$9.33K | ﹤0.01% | 3188 |
|
|
2024
Q3 | $15.7K | Sell |
852
-230
| -21% | -$4.71K | ﹤0.01% | 3212 |
|
|
2024
Q2 | $23.3K | Sell |
1,082
-1,095
| -50% | -$25.1K | ﹤0.01% | 3003 |
|
|
2024
Q1 | $58.6K | Sell |
2,177
-4,190
| -66% | -$119K | ﹤0.01% | 2607 |
|
|
2023
Q4 | $191K | Sell |
6,367
-3,194
| -33% | -$70.5K | ﹤0.01% | 2029 |
|
|
2023
Q3 | $196K | Buy |
9,561
+8,230
| +618% | +$150K | ﹤0.01% | 1840 |
|
|
2023
Q2 | $26.4K | Buy |
1,331
+113
| +9% | +$2.28K | ﹤0.01% | 2836 |
|
|
2023
Q1 | $20.9K | Buy |
1,218
+30
| +3% | +$587 | ﹤0.01% | 2963 |
|
|
2022
Q4 | $23.2K | Sell |
1,188
-91
| -7% | -$1.68K | ﹤0.01% | 2921 |
|
|
2022
Q3 | $20K | Sell |
1,279
-346
| -21% | -$5.4K | ﹤0.01% | 3019 |
|
|
2022
Q2 | $22K | Sell |
1,625
-8,659
| -84% | -$103K | ﹤0.01% | 3002 |
|
|
2022
Q1 | $164K | Buy |
10,284
+1,150
| +13% | +$19.9K | ﹤0.01% | 2041 |
|
|
2021
Q4 | $199K | Buy |
9,134
+1,344
| +17% | +$36.7K | ﹤0.01% | 1977 |
|
|
2021
Q3 | $233K | Buy |
7,790
+1,902
| +32% | +$69.2K | ﹤0.01% | 1904 |
|
|
2021
Q2 | $261K | Buy |
5,888
+811
| +16% | +$35.2K | ﹤0.01% | 1863 |
|
|
2021
Q1 | $225K | Buy |
5,077
+4,822
| +1,891% | +$265K | ﹤0.01% | 1873 |
|
|
2020
Q4 | $14K | Buy |
255
+142
| +126% | +$5.18K | ﹤0.01% | 3060 |
|
|
2020
Q3 | $3K | Buy |
+113
| New | +$2.78K | ﹤0.01% | 3437 |
|
Other funds holding RCKT
RI
VPM
VCM
MC
NM
N
